227 related articles for article (PubMed ID: 10037103)
1. Natural history of dysplasia of the uterine cervix.
Holowaty P; Miller AB; Rohan T; To T
J Natl Cancer Inst; 1999 Feb; 91(3):252-8. PubMed ID: 10037103
[TBL] [Abstract][Full Text] [Related]
2. Dysplasia and the natural history of cervical cancer: early results of the Toronto Cohort Study.
Narod SA; Thompson DW; Jain M; Wall C; Green LM; Miller AB
Eur J Cancer; 1991; 27(11):1411-6. PubMed ID: 1835857
[TBL] [Abstract][Full Text] [Related]
3. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
4. Is the HSIL subclassification cytologically real and clinically justified?
Milicić-Juhas V; Pajtler M
Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108
[TBL] [Abstract][Full Text] [Related]
5. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1.
Ideström M; Milsom I; Andersson-Ellström A
Acta Obstet Gynecol Scand; 2003 Aug; 82(8):756-61. PubMed ID: 12848648
[TBL] [Abstract][Full Text] [Related]
6. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
7. Observations on the development of dysplasia.
Heinzl S; Szalmay G; Jochum L; Roemer V
Acta Cytol; 1982; 26(4):453-6. PubMed ID: 6957097
[TBL] [Abstract][Full Text] [Related]
8. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
Pairwuti S
Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
[TBL] [Abstract][Full Text] [Related]
9. Cervical dysplasia in pregnancy: progression versus regression post-partum.
Siddiqui G; Kurzel RB; Lampley EC; Kang HS; Blankstein J
Int J Fertil Womens Med; 2001; 46(5):278-80. PubMed ID: 11720201
[TBL] [Abstract][Full Text] [Related]
10. Progression and regression of cervical lesions. Review of smears from women followed without initial biopsy or treatment.
Spriggs AI; Boddington MM
J Clin Pathol; 1980 Jun; 33(6):517-22. PubMed ID: 7400354
[TBL] [Abstract][Full Text] [Related]
11. Pap smears with reactive cellular changes: a prospective study.
Ding DC; Hsu S; Chen SS; Hsu YH
J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
[TBL] [Abstract][Full Text] [Related]
12. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of moderate dysplasia. Predictive value of selected markers in routinely prepared cervical smears.
Rosenthal DL; Philippe A; Hall TL; Harami S; Missirlian N; Suffin SC
Anal Quant Cytol Histol; 1987 May; 9(2):165-8. PubMed ID: 3606775
[TBL] [Abstract][Full Text] [Related]
14. Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening.
Muramatsu T; Yoshitake T; Iida T; Yamashita E; Hirasawa T; Miyamoto T; Murakami M; Matsui N; Kajiwara H; Yasuda M; Osamura RY; Mikami M
Tokai J Exp Clin Med; 2006 Dec; 31(4):141-5. PubMed ID: 21302243
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the HPV L1 capsid protein in prognosis of mild and moderate dysplasia of the cervix uteri.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Manestar M
Coll Antropol; 2010 Jun; 34(2):419-23. PubMed ID: 20698112
[TBL] [Abstract][Full Text] [Related]
16. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
Skorstengaard M; Lynge E; Suhr J; Napolitano G
BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
[TBL] [Abstract][Full Text] [Related]
17. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
[TBL] [Abstract][Full Text] [Related]
18. The significance of cervical cytologic dysplasia.
Jordan SW; Smith NL; Dike LS
Acta Cytol; 1981; 25(3):237-44. PubMed ID: 6942614
[TBL] [Abstract][Full Text] [Related]
19. The significance of moderate and severe inflammation on class I Papanicolaou smear.
Lawley TB; Lee RB; Kapela R
Obstet Gynecol; 1990 Dec; 76(6):997-9. PubMed ID: 2234731
[TBL] [Abstract][Full Text] [Related]
20. Malignancy associated changes in cervical smears: systematic changes in cytometric features with the grade of dysplasia.
Guillaud M; Doudkine A; Garner D; MacAulay C; Palcic B
Anal Cell Pathol; 1995 Oct; 9(3):191-204. PubMed ID: 8562458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
